Article info

Download PDFPDF
Extended report
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

Authors

  1. Correspondence to Dr John W Baddley, Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, 1900 University Boulevard, 229 Tinsley Harrison Tower, Birmingham, AL 35294-0006, USA; jbaddley{at}uab.edu
View Full Text

Citation

Baddley JW, Winthrop KL, Chen L, et al
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

Publication history

  • Received February 5, 2013
  • Revised May 21, 2013
  • Accepted July 1, 2013
  • First published July 13, 2013.
Online issue publication 
October 05, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.